These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29486769)

  • 1. Association of chronic fatigue syndrome with premature telomere attrition.
    Rajeevan MS; Murray J; Oakley L; Lin JS; Unger ER
    J Transl Med; 2018 Feb; 16(1):44. PubMed ID: 29486769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G; Maes M
    Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot cross-sectional investigation of symptom clusters and associations with patient-reported outcomes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-19 Condition.
    Weigel B; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
    Qual Life Res; 2024 Dec; 33(12):3229-3243. PubMed ID: 39361124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
    Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Lim EJ; Son CG
    J Transl Med; 2020 Jul; 18(1):289. PubMed ID: 32727489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study.
    Bretherick AD; McGrath SJ; Devereux-Cooke A; Leary S; Northwood E; Redshaw A; Stacey P; Tripp C; Wilson J; Chowdhury S; Lewis I; Almelid Ø; Baby SV; Baker T; Becher H; Boutin T; Clyde M; Garcia D; Ireland J; Kerr SM; McDowall E; Perry D; Samms GL; Vitart V; Wolfe JC; Ponting CP
    NIHR Open Res; 2023; 3():20. PubMed ID: 37881452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
    Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the PROMIS
    Yang M; Keller S; Lin JS
    Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Health-Related Quality of Life in Adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Impact of Core Symptoms.
    Roma M; Marden CL; Flaherty MAK; Jasion SE; Cranston EM; Rowe PC
    Front Pediatr; 2019; 7():26. PubMed ID: 30828572
    [No Abstract]   [Full Text] [Related]  

  • 15. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    de Vega WC; Herrera S; Vernon SD; McGowan PO
    BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After SARS-CoV-2 Infection.
    Unger ER; Lin JS; Wisk LE; Yu H; L'Hommedieu M; Lavretsky H; Montoy JCC; Gottlieb MA; Rising KL; Gentile NL; Santangelo M; Venkatesh AK; Rodriguez RM; Hill MJ; Geyer RE; Kean ER; Saydah S; McDonald SA; Huebinger R; Idris AH; Dorney J; Hota B; Spatz ES; Stephens KA; Weinstein RA; Elmore JG;
    JAMA Netw Open; 2024 Jul; 7(7):e2423555. PubMed ID: 39046739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
    Maes M; Twisk FN; Johnson C
    Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic fatigue syndrome--a clinically empirical approach to its definition and study.
    Reeves WC; Wagner D; Nisenbaum R; Jones JF; Gurbaxani B; Solomon L; Papanicolaou DA; Unger ER; Vernon SD; Heim C
    BMC Med; 2005 Dec; 3():19. PubMed ID: 16356178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study.
    Castro-Marrero J; Faro M; Aliste L; Sáez-Francàs N; Calvo N; Martínez-Martínez A; de Sevilla TF; Alegre J
    Psychosomatics; 2017; 58(5):533-543. PubMed ID: 28596045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.